DK1127137T3 - LPS med reduceret toksicitet fra genetisk modificerede gram-negative bakterier - Google Patents
LPS med reduceret toksicitet fra genetisk modificerede gram-negative bakterierInfo
- Publication number
- DK1127137T3 DK1127137T3 DK98954832T DK98954832T DK1127137T3 DK 1127137 T3 DK1127137 T3 DK 1127137T3 DK 98954832 T DK98954832 T DK 98954832T DK 98954832 T DK98954832 T DK 98954832T DK 1127137 T3 DK1127137 T3 DK 1127137T3
- Authority
- DK
- Denmark
- Prior art keywords
- lps
- molecule
- acyl chains
- recombinant
- glucosamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
- C07H11/04—Phosphates; Phosphites; Polyphosphates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/NL1998/000633 WO2000026384A1 (en) | 1998-11-03 | 1998-11-03 | Lps with reduced toxicity from genetically modified gram negative bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
DK1127137T3 true DK1127137T3 (da) | 2008-01-02 |
DK1127137T4 DK1127137T4 (da) | 2014-02-10 |
Family
ID=19866463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98954832.6T DK1127137T4 (da) | 1998-11-03 | 1998-11-03 | LPS med reduceret toksicitet fra genetisk modificerede gram-negative bakterier |
Country Status (12)
Country | Link |
---|---|
US (1) | US6482807B1 (da) |
EP (2) | EP1127137B2 (da) |
JP (1) | JP3595264B2 (da) |
AT (1) | ATE373714T1 (da) |
AU (1) | AU762369B2 (da) |
CA (1) | CA2348928C (da) |
DE (1) | DE69838460T3 (da) |
DK (1) | DK1127137T4 (da) |
ES (1) | ES2294821T5 (da) |
NZ (1) | NZ511438A (da) |
PT (1) | PT1127137E (da) |
WO (1) | WO2000026384A1 (da) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6887483B2 (en) * | 1995-12-01 | 2005-05-03 | University Of Iowa Research Foundation | Non-toxic mutants of pathogenic gram-negative bacteria |
GB9918319D0 (en) * | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
ES2305086T3 (es) * | 2000-05-19 | 2008-11-01 | Corixa Corporation | Tratamiento profilactico y terapeutico de enfermedades alergicas, autoinmunes e infecciosas con compuestos con base de monosacaridos. |
MXPA03000822A (es) * | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
JP2004510746A (ja) * | 2000-10-06 | 2004-04-08 | パラディース,ハー.,ヘンリッヒ | 免疫調節効果を有する自家ワクチンとしてのカイバードラッグ |
WO2002080964A1 (en) * | 2001-04-06 | 2002-10-17 | Institut Pasteur | Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of vibrio cholerae 0139 bound to tetanus toxoid |
PT2255826E (pt) | 2002-08-02 | 2016-06-08 | Glaxosmithkline Biologicals Sa | Composições de vacina de neisseria compreendendo uma combinação de antigénios |
US20070134214A1 (en) * | 2003-08-13 | 2007-06-14 | Feng Xu | Inactivated host cell delivery of polynucleotides encoding immunogens |
ATE464066T1 (de) * | 2004-05-11 | 2010-04-15 | Staat Der Nederlanden Vert Doo | Neisseria meningitidis igtb los als adjuvans |
PL1828378T3 (pl) * | 2004-12-17 | 2014-10-31 | De Staat Der Nederlanden Vert Door De Mini Van Vws Mini Van Volksgezondheid Welzijn En Sport | Deacylacja lps w bakteriach gram ujemnych |
CN101107007B (zh) | 2005-01-27 | 2011-08-17 | 奥克兰儿童医院及研究中心 | 对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗 |
US20090123499A1 (en) | 2006-06-12 | 2009-05-14 | Nathalie Devos | Vaccine |
PT2134743E (pt) * | 2007-03-26 | 2012-12-21 | Nederlanden Staat | Vacinas melhoradas contra bordotella pertussis baseadas nos mutantes do lps glicosiltransferase |
CA2695467A1 (en) * | 2007-08-02 | 2009-03-26 | Children's Hospital & Research Center At Oakland | Fhbp- and lpxl1-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
DK2200642T3 (da) | 2007-10-19 | 2012-07-16 | Novartis Ag | Meningococvaccinepræparater |
CA2747340A1 (en) | 2008-12-17 | 2010-06-24 | Novartis Ag | Meningococcal vaccines including hemoglobin receptor |
AU2010227219B2 (en) | 2009-03-24 | 2014-02-27 | Glaxosmithkline Biologicals S.A. | Adjuvanting meningococcal factor H binding protein |
JP5668049B2 (ja) | 2009-03-24 | 2015-02-12 | ノバルティス アーゲー | 髄膜炎菌h因子結合タンパク質および肺炎球菌糖結合体の組み合わせ |
WO2010130898A2 (fr) | 2009-05-14 | 2010-11-18 | Sanofi Pasteur | Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6 |
CA2761916A1 (fr) | 2009-05-14 | 2010-11-18 | Sanofi Pasteur | Procede pour adjuver le lipopolysaccharide (lps) des bacteries a gram-negatif |
CN102740882A (zh) | 2009-08-27 | 2012-10-17 | 诺华有限公司 | 含有铝、寡核苷酸和聚阳离子的佐剂 |
JP2013521327A (ja) | 2010-03-10 | 2013-06-10 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
CA2793510A1 (en) | 2010-03-18 | 2012-02-16 | Novartis Ag | Adjuvanted vaccines for serogroup b meningococcus |
US20130066064A1 (en) * | 2010-05-20 | 2013-03-14 | Glaxosmithkline Biologicals S.A, | Novel process |
AU2011268507B2 (en) | 2010-06-25 | 2014-08-14 | Novartis Ag | Combinations of meningococcal factor H binding proteins |
AU2011300418B2 (en) | 2010-09-10 | 2016-05-12 | Glaxosmithkline Biologicals Sa | Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom |
GB201015132D0 (en) | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
WO2012153302A1 (en) | 2011-05-12 | 2012-11-15 | Novartis Ag | Antipyretics to enhance tolerability of vesicle-based vaccines |
PT2729167T (pt) | 2011-07-07 | 2018-06-20 | Vert Door De Mini Van Vws De Staat Der Nederlanden | Um processo para a produção sem detergente de desículas de membrana externa de uma bactéria gram-negativa |
CA2862247A1 (en) | 2011-12-29 | 2013-07-04 | Novartis Ag | Adjuvanted combinations of meningococcal factor h binding proteins |
RU2014135522A (ru) | 2012-02-02 | 2016-03-27 | Новартис Аг | Промоторы для увеличенной экспрессии белка у менингококка |
US9526776B2 (en) | 2012-09-06 | 2016-12-27 | Glaxosmithkline Biologicals Sa | Combination vaccines with serogroup B meningococcus and D/T/P |
WO2014122232A1 (en) | 2013-02-07 | 2014-08-14 | Novartis Ag | Pharmaceutical compositions comprising vesicles |
US20160120967A1 (en) | 2013-06-04 | 2016-05-05 | Petr Gennadievich Aparin | Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants) |
AU2016206965B2 (en) | 2015-01-12 | 2021-03-04 | Children's Medical Center Corporation | Pro-inflammatory and adjuvant functions of toll-like receptor 4 antagonists |
EP3408275A1 (en) * | 2016-01-28 | 2018-12-05 | De Staat der Nederlanden, vert. door de minister Van VWS, Ministerie van Volksgezondheid, Welzijn en Sport | Modified hexa-acylated neisserial lps |
EP3263695A1 (en) | 2016-06-29 | 2018-01-03 | GlaxoSmithKline Biologicals SA | Immunogenic compositions |
JP2023541497A (ja) * | 2020-03-13 | 2023-10-03 | ヘファイストス-ファーマ | 脱酸素化リポ多糖(lps)、天然非毒性lpsおよびそれらの使用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6887483B2 (en) * | 1995-12-01 | 2005-05-03 | University Of Iowa Research Foundation | Non-toxic mutants of pathogenic gram-negative bacteria |
WO1997025061A1 (en) * | 1996-01-09 | 1997-07-17 | Bristol-Myers Squibb Company | De-myristolated lipopolysaccharide of gram-negative bacteria |
-
1998
- 1998-11-03 DE DE69838460.1T patent/DE69838460T3/de not_active Expired - Lifetime
- 1998-11-03 NZ NZ511438A patent/NZ511438A/xx not_active IP Right Cessation
- 1998-11-03 EP EP98954832.6A patent/EP1127137B2/en not_active Expired - Lifetime
- 1998-11-03 AT AT98954832T patent/ATE373714T1/de active
- 1998-11-03 ES ES98954832.6T patent/ES2294821T5/es not_active Expired - Lifetime
- 1998-11-03 EP EP07112938A patent/EP1870468A3/en not_active Withdrawn
- 1998-11-03 CA CA2348928A patent/CA2348928C/en not_active Expired - Fee Related
- 1998-11-03 AU AU11782/99A patent/AU762369B2/en not_active Ceased
- 1998-11-03 US US09/830,910 patent/US6482807B1/en not_active Expired - Lifetime
- 1998-11-03 WO PCT/NL1998/000633 patent/WO2000026384A1/en active IP Right Grant
- 1998-11-03 PT PT98954832T patent/PT1127137E/pt unknown
- 1998-11-03 JP JP2000579756A patent/JP3595264B2/ja not_active Expired - Fee Related
- 1998-11-03 DK DK98954832.6T patent/DK1127137T4/da active
Also Published As
Publication number | Publication date |
---|---|
EP1127137B1 (en) | 2007-09-19 |
JP3595264B2 (ja) | 2004-12-02 |
EP1127137A1 (en) | 2001-08-29 |
WO2000026384A1 (en) | 2000-05-11 |
ES2294821T3 (es) | 2008-04-01 |
US6482807B1 (en) | 2002-11-19 |
DE69838460T2 (de) | 2008-06-12 |
DE69838460T3 (de) | 2014-04-30 |
PT1127137E (pt) | 2007-12-28 |
EP1870468A3 (en) | 2010-01-13 |
CA2348928A1 (en) | 2000-05-11 |
NZ511438A (en) | 2003-03-28 |
ES2294821T5 (es) | 2014-03-05 |
CA2348928C (en) | 2010-01-26 |
DK1127137T4 (da) | 2014-02-10 |
ATE373714T1 (de) | 2007-10-15 |
JP2002528558A (ja) | 2002-09-03 |
DE69838460D1 (de) | 2007-10-31 |
EP1127137B2 (en) | 2013-12-25 |
AU762369B2 (en) | 2003-06-26 |
EP1870468A2 (en) | 2007-12-26 |
AU1178299A (en) | 2000-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1127137T3 (da) | LPS med reduceret toksicitet fra genetisk modificerede gram-negative bakterier | |
PT618190E (pt) | 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas | |
ATE168992T1 (de) | 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline | |
ITMI930366A0 (it) | Addittivi superfluidificanti ad elevata conservazione della lavorabilita' | |
LV12516A (en) | Inhibitors of factor xawith a neutral p1 specifity group | |
ES2162617T3 (es) | Nuevas 7-(sustituido)-8-(sustituido)-9-((glicilo sustituido)amido)-6-desmetil-6-desoxitetraciclinas. | |
FI933567A0 (fi) | Nya 7-(substituerad)-8-(substituerad)-9-(substituerad amino)-6-demetyl-6-deoxitetracykliner | |
TW269678B (da) | ||
FI932103A0 (fi) | Nya 4-arylpiperaziner och 4-arylpiperidiner | |
YU40997A (sh) | Novi oksadiazoli, postupci za njihovo pripremanje | |
MX9700557A (es) | Dihidrobenzofuranos. | |
DE69221174D1 (de) | Anordnung für Feldemissions-Mikrokathoden | |
CY1104996T1 (el) | 9α-αζαλιδια εχοντα αντιβακτηριακην δρασιν | |
ATE222115T1 (de) | Verbesserung der antibakteriellen wirkung von oxazolidinon durch arginin derivate | |
ATE143369T1 (de) | Überbrückte, cyclische ketale | |
DE69528074D1 (de) | Chitosan induzierte verstärkung | |
FI931079A (fi) | Mikrobmotverkande karbapenemderivat, deras framstaellning och terapeutiska anvaendning | |
ATE361931T1 (de) | N1 modifizierte glycopeptide | |
EA200101103A1 (ru) | НОВЫЕ 15-ЧЛЕННЫЕ 8а- И 9а ЛАКТАМЫ | |
DE69212267T2 (de) | Echinocandin-B-Derivat | |
BR9106596A (pt) | Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto | |
IT1262952B (it) | Tetraalchilpiperidine, loro preparazione e loro impiego come stabilizzanti alla luce. (caso 153-5502) | |
IT1265314B1 (it) | Acilsulfammidi ad attivita' antitumorale |